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Abstract—A Fabry-Pérot based optical fiber sensor to measure 
the oxygen concentration through monitoring the change of 
refractive index in red blood cells is reported. The optical fiber 
sensor with a diameter of 220 μm is made entirely of fused silica 
glass fibers which can be integrated within standard 
brachytherapy seed delivery needle to be used in-vivo. Iso-
propanol solution and pig blood are prepared to produce 
refractive index in the range 1.344 to 1.365. Gold is coated to a 
thickness of 100 nm at the tip of the sensor to enhance the 
interaction between hemoglobin and light. A Fast Fourier 
Transform algorithm is used to analyze the phase angle from the 
reflected output spectrum. The gold-coated sensor has up to 
almost ten times higher sensitivity to hemoglobin concentration in 
blood solutions compared to iso-propanol solutions. A sensitivity 
of 9.82 rad/RIU with a refractive index resolution of 2.09*10-3 RIU 
is achieved for the sensor with a 16 μm thickness diaphragm. 
 
Index Terms— Optical fiber sensor, Fabry-Pérot 
interferometer, refractive index sensing, hypoxic tumors  
 
I. INTRODUCTION 
UMOR hypoxia is a condition where a solid tumor has 
significantly lower oxygen concentration compared to 
healthy tissues. Hypoxic tumors can be generally found in the 
case of lung, liver, stomach, colorectal, breast, esophageal and 
prostate cancers. Prostate cancer is the most common cancer 
found in men and the second highest cause of cancer death after 
lung cancer [1, 2]. The oxygen concentration in the tumor can 
be defined by percentage of oxygen (%O2) and partial pressure 
of oxygen (pO2) where 1%O2 = 1 mmHg at atmospheric pressure 
1.013 kPa [3]. Generally, the pO2 level in prostate tissue is 30 
mmHg but the hypoxic tumor in prostate cancer has pO2 level 
around 2.4 mmHg on average [4]. The pO2 level in the hypoxic 
tumor varies due to its heterogeneous structure depending only 
on hemoglobin concentration (cHb). The tumor size, grade and 
stage of the development do not have a significant effect on the 
oxygen concentration of the tumors. With cHb of less than 14.5 
g/dl, the hypoxic tumor has a pO2 of 2.2 mmHg whereas a pO2 
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of 3.7 mmHg was found in prostate cancer with cHb ≥ 14.5 g/dl 
[5].   
The hypoxic tumors with an oxygen level below 0.13%O2 
have been identified to have a significant resistance to oncology 
treatment including surgery, chemotherapy and radiotherapy 
[6-10]. Several therapies for hypoxic tumors in prostate cancer 
depend on the stage and grade of the cancer including surgery, 
chemotherapy and radiotherapy. Radiotherapy is a common 
treatment for locally advanced prostate cancer. Radiation 
therapy uses high energy x-rays to destroy the cancer cells and 
it is usually delivered alongside hormone therapy. The radiation 
dose has to be optimized by a radiation oncologist in order to 
effectively eradicate the tumor cells whilst inflicting minimal 
damage to the surrounding healthy tissue.  
The ability to accurately apply the required dosage has 
improved through advances in technologies and research but 
the effectiveness of the treatment still relies on analyzing 
biopsies and imaging modalities and are rarely undertaken in 
real-time. Since the late 1980s, the pO2 in tumor cells has been 
studied and measured using a computerized polarographic 
needle electrode system [11-13]. However, the major 
disadvantage of the electrochemical reduction involved in this 
process is that the electrode consumes O2, which may lead to an 
underestimation of the pO2 level. Recently, a commercially-
available optical sensor for hypoxic measurement through 
fluorescence quenching technique has emerged (Oxylite TM) 
[14]. Its operation is based on measuring the optical absorption 
due to the presence of O2 in tumors. However, the sensor cannot 
be used in-vivo due to an FDA approval issue and is not suitable 
for use under irradiation conditions. Hence, at present there is 
no sensor that can be used to access hypoxic tumor in humans 
for real-time measurement during the radiotherapy. 
In this work, a novel Fabry-Pérot based optical fiber sensor 
is introduced to directly measure the oxygen level in the 
hypoxic tumors through the real time measurement of refractive 
index changes in red blood cells during radiation treatment by 
integration into a standard brachytherapy needle. Oxygen is 
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transported throughout the body by the red blood cells which 
consist of a protein called hemoglobin (Hb) as a main 
component. Hemoglobin can chemically bind with oxygen to 
become oxyhemoglobin. There exists previous research using a 
long period grating optical fiber coated with hemoglobin to 
monitor dissolved oxygen. The sensor can detect a shift in 
refractive index when carboxyhemoglobin converts into 
oxyhemoglobin [15]. Hence, the amount of oxygen binding 
with hemoglobin can be indicated by the RI of the hemoglobin 
itself. Different concentrations of hemoglobin (cHb) 
significantly affect the oxygen level in the tumors as well as the 
optical properties of blood such as absorption and scattering. 
The cHb can be characterized by its refractive index which is 
the main parameter to be measured in this paper.  
The Extrinsic Fabry-Pérot Interferometer (EFPI) based 
sensor employed in this investigation comprises a 200 µm outer 
diameter silica glass capillary containing a sealed single mode 
fiber (SMF) of 7 μm/125 μm core/cladding diameter with an 
end cap which has been coated on its external surface with a 
100 nm thick gold layer to enhance the interaction between light 
and hemoglobin. The details of the sensor and its fabrication are 
included in Section II of this article. A recent study reported on 
the ability of titanium dioxide (TiO2) to tune the reflectivity of 
a Fabry-Perot interferometer cavity. With the presence of the 
reflective film, the sensor has the ability to detect the refractive 
index in a range close to the refractive index of silica glass 
optical fiber [16]. A separate recent study included the use of 
functionalized reduced graphene oxide which was coated onto 
an etched Fiber Bragg Grating (FBG) to detect the glycated 
hemoglobin, which is a form of hemoglobin used to identify 
glucose concentration. The sensors provide a high sensitivity to 
the change of glucose and glycated hemoglobin [17]. However, 
the reduced graphene oxide has toxic effects both in-vitro and 
in-vivo. Although, surface modifications can reduce its toxicity, 
further investigations are required to adequately reduce its toxic 
effect and to meet the stringent requirements biomedical 
certifications [18]. In the sensor of this investigation, gold is 
used as the coating material because gold allows hemoglobin to 
bind to the sensor tip without changing its biological function 
[19]. In addition, gold nanoparticles are potentially bio-
compatible and in limited recent studies have gained approval 
by the FDA in several clinical trials for cancer and 
cardiovascular treatments [20-23]. With biocompatible material 
and compact structure, the sensor is designed to be integrated 
within a standard brachytherapy needle to provide real-time 
measurement of the refractive index inside the prostate gland 
during radiation treatment. 
This paper presents the fabrication process of a novel gold-
coated Fabry-Pérot based optical fiber sensor. The sensors were 
tested initially using various concentrations of iso-propanol 
with water solutions and were followed by further pig blood 
solutions in water providing refractive index values in the 
ranges of 1.344-1.365 and 1.343-1.348 in the visible region, 
respectively. Iso-propanol was selected owing to the similarity 
in values of RI to the hemoglobin environment targeted in this 
investigation. The pig blood tests were conducted to realize the 
effect of the thin gold layer when exposed to hemoglobin based 
protein. A Fast Fourier Transform (FFT) algorithm was used to 
extract the phase angle from the reflected spectrum and the 
phase shift arising from the change of refractive index was 
measured while assuming the oxyhemoglobin is fully saturated. 
II. DESIGN AND FABRICATION 
A. Design of Fabry-Pérot based optical fiber sensor 
The Fabry-Pérot based optical fiber sensor was made only of 
fused silica glass including a standard single-mode fiber (SMF-
28E), a capillary and a multimode fiber (MMF). The sensor was 
designed as a Fabry-Pérot configuration as shown in Fig. 1. The 
basic fabrication process was initially described by Poeggel et 
al [24] and further details of the fabrication of the sensor of this 
investigation are provided in Section B below. The sensor of 
Poeggel et al [24] was designed to measure urodynamic 
pressure changes and included an end-cap flexible diaphragm 
of 2 µm thickness.  However, in the investigation described in 
this article there is no requirement to measure pressure and the 
diaphragm thickness has been increased to 15-30 µm in order 
to render it inflexible for the pressure levels encountered within 
a prostate tumor.  A thin gold layer of thickness 100 nm was 
coated by using a sputtering technique on the tip of the sensor 
which is the contact sensing area. A 5nm thick layer of titanium 
was also sputtered prior to applying the gold coating which 
provides an adhesive layer for the gold which is also 
biocompatible and exhibits no oxidation when used with gold.   
The sensor is designed to have three Fabry-Pérot layers 
consisting of (i) SMF/air/MMF, (ii) air/MMF/gold and (iii) 
MMF/gold/sensing region. There are four interfaces including 
in the sensor (R1 R2, R3and R4) as labeled in Fig. 1, which are 
RSMF,air, Rair,MMF, RMMF,gold and Rgold,sensing, respectively. The 
output signal of each Fabry-Pérot configuration is reflected 
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where d is cavity width, n is refractive index of the cavity and λ 
is the operating wavelength (λ=1530-1590 nm). Rm1 and Rm2 are 
the reflectivity of both reflecting surfaces. The reflectivity of 
each interface can be defined as the square of the magnitude of 
the Fresnel reflection coefficient in the case of normal incidence 
 
 
Fig.1. Schematic of Fabry-Pérot based optical fiber sensor. 
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The defined parameters for the three Fabry-Pérot sections are; 
(i) d is the air gap width (dair) which is in range 20-30 µm, 
Rm1 and Rm2 are RSMF,air and Rair,MMF. 
(ii) d is the diaphragm thickness (ddiaphragm) which is around 
15-30 µm, Rm1 and Rm2 are Rair,MMF and RMMF,gold. 
(iii) d is the gold thickness (dgold) which is 100 nm, Rm1 and 
Rm2 are RMMF,gold and Rgold,sensing. 
The diaphragm thickness is designed to be 15-30 µm to avoid 
cross-sensitivity from pressure. In this work, Rgold,sensing is a key 
parameter that affects the output spectrum due to the change of 
refractive index in the sensing region (nsensing). 
B. Fabrication of Fabry-Pérot based optical fiber sensor 
Three essential optical components were used to fabricate the 
sensor which are (i) standard Single Mode Fiber, SMF-28E 
(=125μm), (ii) a glass capillary (i=132μm and o=220μm) 
and (iii) a Multi-Mode Fiber, MMF (=200μm). Initially, the 
MMF and capillary were polished with different grit sizes of 
Al2O3 polishing paper including 12 µm, 3 µm, 1 µm and 0.3 µm 
to achieve flat and clean surface in preparation for fusion 
splicing. After cleaning the polished fibers with isopropanol in 
sonicator, the MMF and capillary were fused together as shown 
in Fig. 2(a). The fusion splicer used was an ERICSSON FSU-
975 with a fusion feed distance of 7 µm and a fusion current of 
10.3 mA was applied for 3 seconds. The SMF was inserted into 
the capillary leaving an air gap of 20-30 μm between its end and 
the MMF as shown in Fig. 2(b) and (c). The fusion condition 
for the capillary/SMF was 11mA fusion current applied for 10 
seconds with the fusion feed distance of 0 μm. The air gap width 
(dair) can be adjusted by observing the wavelength separation 
between reflected peaks in the output spectrum and using the 
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where λ1 and λ2 are the two adjacent wavelength peaks, Δλ is the 
distance between the two adjacent peaks and n is the refractive 
index of the cavity. 
The MMF joined to the capillary was then cut and polished 
to achieve the desired end cap thickness which is around 15-30 
µm as shown in Fig. 2(d). The thickness of the MMF, which 
forms the end cap or diaphragm of the sensor, can be controlled 
by matching the output interference pattern of the reflected 
spectra with the simulated spectrum obtained from an in-house 
developed program. The Fabry-Pérot based optical fiber sensor 
was coated with the thin gold layer on the diaphragm using a 
standard sputtering technique. Titanium was coated first to 
provide adhesion for the gold layer. The sputtering rate for 
titanium was set to 0.4 Å/s with Power, P= 80 W for 2.8 mins 
to obtain a 5 nm thick layer. For the gold layer, the sputtering 
rate was 2.1 Å/s with Power, P= 20 W for 8 mins to achieve a 
thickness of 100 nm. The tip of the sensor before and after 
coating the gold layer is shown as separate micrographs in Figs. 
3(a) and (b), respectively. For the purpose of this investigation, 
total 4 sensors with a diaphragm thickness (td) of 16, 18, 28 and 
31 µm were fabricated. 
III. EXPERIMENTAL RESULTS 
The Fabry-Pérot based optical fiber sensors were designed to 
be able to measure a change of the refractive index in the 
sensing region. In the experimental part, non-coated and gold-
coated optical fiber sensors were tested with different volume 
ratios of iso-propanol solution to investigate the effect of the 
gold layer on the sensors. Then, the gold-coated sensor was 
analyzed using different hemoglobin concentrations in pig 
blood/water solution to study the effect of the gold layer on red 
blood cells.  
In this paper we have restricted the hemoglobin generation 
by using only mixtures of pig blood and water without any pre-
treatment to keep the blood being in real condition. The 
potential cross-sensitivity problem has been minimized in this 
case. In a complex structure/medium such as human tissue there 
are several potential interfering parameters e.g. extraneous 
cells, fat globules, air pockets and when this sensor is 
introduced into this environment these are issues that will need 
to be addressed.  However, even before this, it will be necessary 
to conduct the experiment in standard tissue phantoms, this 
 
Fig.3. Optical microscope image of the sensor tip (a) without gold 
coating and (b) with gold coating. 
 
 
Fig. 2. Fabrication process of Fabry-Pérot based optical fiber sensor. 




being a highly controlled environment. The fact that we are 
capturing a broad band spectral signal (= 1530 to 1590 nm) 
may also form a strength of this approach as any particular 
absorption due to molecular species may also affect the signal 
in a unique manner.  
A. Solutions preparation 
1) Iso-propanol solutions 
The iso-propanol solutions were prepared by mixing iso-
propanol with distilled water in volume ratios of 1:5, 1:3, 1:2, 
1.5 and 1:1 and were referred to as ISO15, ISO13, ISO12, 
ISO115 and ISO11, respectively. The refractive indices of the 
solutions were measured using a standard ABBE-REF1 
refractometer in the visible region at T = 21.6˚C and were found 
to be 1.344, 1.351, 1.355, 1.360 and 1.365 for ISO15, ISO13, 
ISO12, ISO115 and ISO11, respectively, as shown in TABLE 
I.  
 
2) Pig blood solutions  
Fresh pig blood was obtained from a 180-day-old pig which 
usually has a hemoglobin concentration (cHb) of 9.55 g/dl [27]. 
Blood is a composed of blood cells and blood plasma. The 
blood plasma is mostly water which is about 92% by volume 
whereas the blood cells are mainly red blood cells which 
account for about 99% of the cells. The red blood cells contain 
hemoglobin which is responsible for transporting and 
distributing the oxygen throughout the body. The refractive 
index of blood is determined by the refractive index of the 
hemoglobin (nHb) which depends strongly on the hemoglobin 
concentration (CHb) and operating wavelength. nHb can also be 
calculated from Barer’s formular [28]: 
 
 HbOHHb αCnn 2   (4) 
 
where OH2n  is the refractive index of water which is the main 
component in blood plasma.  α is specific refraction increment 
which is inversely proportional to the operating wavelength. 
 The blood solutions in this work were prepared by mixing 
the fresh pig blood with distilled water with the blood fraction 
of 0.5, 0.6, 0.7, 0.8, 0.9 and 1.0 and referred to as B1, B2, B3, 
B4 and B5, respectively. The refractive index of the blood 
solutions was measured using an ABBE-REF1 refractometer in 
the visible region. The refractive increment parameter (α) in the 
equation (4), which is proportionality constant being 
characterized of the individual protein at the specific 
wavelengths, is calculated to be 0.0011 with a linear regression 
coefficient (R2) of 0.9075 in this case. The refractive index for 
each blood solution was measured to be 1.3427, 1.3431, 1.3438, 
1.3444, 1.3460 and 1.3482 for the solutions B1, B2, B3, B4 and 
B5, respectively, as shown in TABLE II. 
B.  Phase shift analysis 
The output signal of the Fabry-Pérot based optical fiber 
sensors is an interference pattern of the reflected spectrums as 
shown in Fig. 4(a). The operating wavelength is between 1530 
and 1590 nm. A Fast Fourier Transform (FFT) algorithm was 
applied to the spectrum and used to extract the phase angle from 
the resulting phase spectrum. The FFT of the reflected spectra 
shown in Fig. 4(a) is presented in Fig. 4(b).  Distilled water was 
used as the reference sensing material. Hence, the phase angle 
obtained from the FFT of the reflected spectrum tested with 
water was used as the reference peak. Once the sensing material 
was introduced to either iso-propanol or blood solutions, the 
 
Fig. 4. (a)  Interference pattern of the reflected spectrums and (b) their 
FFT in different refractive index solutions. 
TABLE I 
REFRACTIVE INDICES OF ISO-PROPANOL SOLUTIONS WITH DIFFERENT 
VOLUME RATIOS AT T=21.6C 
Solution 
Mixture of Isopropanol : Water Refractive 
index (n) By ratio By volume (ml) 
Water 0:1 0:30 1.3359 
ISO15 1:5 5:25 1.3438 
ISO13 1:3 7:21 1.3515 
ISO12 1:2 10:20 1.3554 
ISO115 1:1.5 12:18 1.3596 
ISO11 1:1 15:15 1.3655 
 
TABLE II 
REFRACTIVE INDICES AND O2 CONTENTS OF PIG BLOOD SOLUTIONS WITH 
DIFFERENT HEMOGLOBIN CONCENTRATIONS 
Solutions Blood fraction cHb (g/dl) nHb 
B1 0.5 4.775 1.34266 
B2 0.6 5.730 1.34306 
B3 0.7 6.685 1.34382 
B4 0.8 7.640 1.34442 
B5 0.9 8.595 1.34600 
B6 1.0 9.550 1.34824 
 




phase angle shifted from the reference value due the change of 
refractive index in the sensing region which can also be seen in 
Fig. 4 (b). The measurement set for each experiment was 
repeated ten times and the variations are represented as error 
bars (standard deviation) in each case. 
C. Effect of diaphragm thickness 
 The non-coated Fabry-Pérot based optical fiber sensors with 
diaphragm thicknesses of 18 μm and 31 μm were studied with 
iso-propanol solutions to investigate the effect of the diaphragm 
thickness [29]. The phase difference of both sensors between 
three different iso-propanol solutions (n=1.344, 1.351 
and1.365) and water (n=1.336) is shown in Fig. 5 [29]. It can 
be seen that sensor with an 18 μm diaphragm thickness has a 
sensitivity of 2.189 rad/RIU. It is higher than the sensitivity of 
a 31 μm thick diaphragm sensor which is 0.719 rad/RIU. This 
is most likely due to a static phase shift from the diaphragm 
which affects the dynamic phase shift with refractive index 
changes at the external boundary.  
D. Effect of the gold coating when used to measured iso-
propanol  
The Fabry-Pérot based optical fiber sensors were coated with 
a 100 nm thick gold layer and tested again with iso-propanol 
solutions to study the effect of the gold coating on iso-propanol 
solutions. The phase difference obtained from non-coated and 
gold-coated sensors at each iso-propanol solution for 28 μm end 
caps (diaphragms) is shown in Fig. 6. It can be observed that 
gold-coated sensors have lower sensitivities compared to the 
non-coated sensors when tested with iso-propanol solutions. 
This is because the gold layer coated at the tip of the sensors 
acts purely as a reflecting medium allowing a smaller amount 
of light to be transmitted. There is no chemical binding in 
existence between the iso-propanol solution and the gold layer. 
Therefore, the light interaction with the analyte material, which 
is iso-propanol solution, is reduced leading to a lower 
sensitivity.  
E. Effect of the gold coating when used to measured blood 
Generally, there is a spontaneous binding process between 
biomolecules and ligands which are ions or small molecules 
attached with a metal atom. In this case, the biomolecule is 
hemoglobin which can bind with gold nanoparticles. The phase 
 
 
Fig. 6. Relationship between phase difference and the refractive indices 
of three differnet iso-propanol solutions of the non-coated and gold-coated 
Fabry-Pérot based sensors with the diaphragn thickness of 28 µm. 
 
Fig. 7. Relationship between phase difference and the refractive indices 
of five differenet pig blood solutions compared with the same range of 
refractive indices of iso-propanol solutions for the Fabry-Pérot based 
sensors with (a) 18 µm and (b) 28 µm thick diaphragm.  
 
 
Fig. 5. Relationship between phase difference and the refractive indices 
of three differnet iso-propanol solutions of the 18 µm and 31 µm thick 
diaphragm Fabry-Pérot based sensors .  




difference of the gold-coated optical fiber sensor tested with the 
blood solutions was compared with the phase difference when 
the sensor was tested with iso-propanol solutions to investigate 
the effect of gold on hemoglobin in red blood cells as shown in 
Fig. 7 in which Fig. 7(a) shows the comparison for the 18μm 
thick diaphragm sensor and the comparison for the diaphragm 
of thickness 28 μm is shown in Fig. 7(b). It can be clearly seen 
that both of the gold-coated sensors have a greater sensitivity to 
the presence of hemoglobin in blood.  
F. Sensor resolution 
The resolution of this Fabry-Pérot based optical fiber sensors 
is defined by the minimum refractive index changes that can be 
detected by the sensor. It was calculated by dividing the largest 
standard deviation of each sensor by the sensitivity of the 
sensor. Each sensor has different sensitivity and standard 
deviation as presented in TABLE III. The resolutions of four 
sensors (td = 16, 18, 28 and 31 µm) are in the range of 10-3 RIU 
where the sensor with the diaphragm thickness of 16 µm has the 
maximum (worst case) resolution value of 6.8727 x10-3 RIU. 
G. O2 concentration related to refractive index 
The concentration of oxygen in solution (C) can be computed 
from dissolved oxyhemoglobin using oxygen dissociation 
curve of hemoglobin as [30]:  
 
 )ScHb.()OP.(C a  410030 2  (5) 
 
where PaO2 is the arterial partial pressure at sea level (mmHg), 
cHb is the hemoglobin concentration (g/dl) and S is percentage 
saturation of O2. The oxyhemoglobin is hemoglobin bound with 
oxygen molecules which can have different percentage 
saturation. In this work, fully saturated hemoglobin (100% O2 
saturated) is assumed leading to PaO2 = 100 mmHg [31]. Hence, 
the amount of oxygen for each solution depending on the 
hemoglobin concentration in TABLE II can be calculated and 
plotted as shown in Fig. 8.  
The relation between the amount of O2 (C) and refractive 
index in the visible region can be determined as a quadratic fit 
depicted by the continuous line in Fig. 8. The calculated R2 
value for this fitting curve was 0.9909. The following equation 
can be used to describe the O2 concentration versus refractive 
index relationship: 
 
 ).(n).(n).(C 5525 1093108510152   (6) 
 
where C has units of ml/dl. 
IV. CONCLUSION 
A Fabry-Pérot based optical fiber has been developed to 
measure the oxygen concentration through measurement of 
refractive index changes of hemoglobin in red blood cells. Two 
types of sensor were developed for this study being non-coated 
and gold-coated sensors. In this work, iso-propanol and fresh 
pig blood were used as sensing materials. The main focus of 
this paper is to investigate the application of a thin gold layer to 
enhance the interaction of hemoglobin at the sensor tip. With 
the presence of hemoglobin in blood solutions, the gold coated 
sensors achieve higher sensitivity compared with the sensor 
when testing with iso-propanol solutions. This is due to a 
spontaneous binding between the gold and hemoglobin. The 
sensors can be further improved in term of sensitivity and 
resolution by optimizing the thickness of the diaphragm and 
gold layer. This work will be extended to investigate solid tissue 
based hemoglobin to study the oxygen level of hypoxic tumors 
which occur as solid tissue objects. 
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